Phase II Study of Pazopanib and Topotecan in Cervical Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of topotecan and
pazopanib can help to control recurrent cervical cancer. The safety of the study drug
combination will also be studied.